HKD 0.46
(-5.21%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 152.17 Million HKD | -6.85% |
2022 | 163.35 Million HKD | -2.28% |
2021 | 167.17 Million HKD | 26.81% |
2020 | 131.82 Million HKD | -15.03% |
2019 | 155.13 Million HKD | 11.57% |
2018 | 139.04 Million HKD | 0.4% |
2017 | 138.49 Million HKD | 40.76% |
2016 | 98.38 Million HKD | -4.73% |
2015 | 103.27 Million HKD | 7.37% |
2014 | 96.19 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 74.7 Million HKD | 0.0% |
2023 Q1 | 31.39 Million HKD | -63.24% |
2023 Q2 | 72.34 Million HKD | 130.42% |
2023 Q3 | 41.02 Million HKD | -43.29% |
2023 Q4 | 79.82 Million HKD | 94.56% |
2023 FY | 152.17 Million HKD | -6.85% |
2022 Q1 | 39.64 Million HKD | -58.25% |
2022 FY | 163.35 Million HKD | -2.28% |
2022 Q4 | 85.4 Million HKD | 98.15% |
2022 Q3 | 43.09 Million HKD | -45.84% |
2022 Q2 | 79.58 Million HKD | 100.74% |
2021 FY | 167.17 Million HKD | 26.81% |
2021 Q1 | 36.84 Million HKD | -50.56% |
2021 Q4 | 94.96 Million HKD | 105.23% |
2021 Q2 | 72.22 Million HKD | 95.99% |
2021 Q3 | 46.27 Million HKD | -35.93% |
2020 Q2 | 64.74 Million HKD | 84.24% |
2020 Q4 | 74.53 Million HKD | 90.01% |
2020 FY | 131.82 Million HKD | -15.03% |
2020 Q1 | 35.14 Million HKD | -57.76% |
2020 Q3 | 39.22 Million HKD | -39.41% |
2019 Q2 | 71.95 Million HKD | 109.3% |
2019 Q1 | 34.37 Million HKD | -49.39% |
2019 FY | 155.13 Million HKD | 11.57% |
2019 Q4 | 83.18 Million HKD | 104.81% |
2019 Q3 | 40.61 Million HKD | -43.55% |
2018 FY | 139.04 Million HKD | 0.4% |
2018 Q4 | 67.92 Million HKD | 135.77% |
2018 Q3 | 28.8 Million HKD | -19.89% |
2018 Q2 | 35.96 Million HKD | 0.0% |
2018 Q1 | 35.96 Million HKD | 24.54% |
2017 Q1 | 25.87 Million HKD | -48.61% |
2017 FY | 138.49 Million HKD | 40.76% |
2017 Q4 | 28.87 Million HKD | 0.0% |
2017 Q3 | 28.87 Million HKD | 11.6% |
2017 Q2 | 25.87 Million HKD | 0.0% |
2016 FY | 98.38 Million HKD | -4.73% |
2016 Q1 | 28.04 Million HKD | 14.0% |
2016 Q2 | 28.04 Million HKD | 0.0% |
2016 Q4 | 50.35 Million HKD | 0.0% |
2016 Q3 | 50.35 Million HKD | 79.58% |
2015 Q4 | 24.59 Million HKD | -4.73% |
2015 Q3 | 25.81 Million HKD | 0.0% |
2015 Q2 | 25.81 Million HKD | 0.0% |
2015 Q1 | 25.81 Million HKD | 0.0% |
2015 FY | 103.27 Million HKD | 7.37% |
2014 FY | 96.19 Million HKD | 0.0% |
2014 Q4 | 25.81 Million HKD | 7.37% |
2014 Q3 | 24.04 Million HKD | 0.0% |
2014 Q2 | 24.04 Million HKD | 0.0% |
2014 Q1 | 24.04 Million HKD | 0.0% |
2013 Q4 | 24.04 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 25.437% |
Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -966.071% |
China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -297.033% |
Prosperous Future Holdings Limited | 118.15 Million HKD | -28.794% |
Huasheng International Holding Limited | 153.46 Million HKD | 0.842% |
Fourace Industries Group Holdings Limited | 57.65 Million HKD | -163.929% |
EC Healthcare | 597.44 Million HKD | 74.53% |
Ming Fai International Holdings Limited | 357.68 Million HKD | 57.456% |
Blue Moon Group Holdings Limited | 4.4 Billion HKD | 96.549% |
SuperRobotics Holdings Limited | 15.16 Million HKD | -903.7% |
Takbo Group Holdings Limited | 65.71 Million HKD | -131.551% |
Hyfusin Group Holdings Limited | 196.91 Million HKD | 22.721% |